HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Raymond Selected Research

ErbB Receptors (EGF Receptor)

6/2003[Epidermal growth factor inhibitors].
11/2002Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.
1/2000Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Raymond Research Topics

Disease

31Neoplasms (Cancer)
05/2015 - 01/2000
7Carcinoma (Carcinomatosis)
10/2008 - 02/2001
4Asthenia
01/2012 - 01/2007
4Neutropenia
01/2009 - 12/2000
3Prostatic Neoplasms (Prostate Cancer)
12/2017 - 05/2000
3Hepatocellular Carcinoma (Hepatoma)
05/2015 - 05/2009
3Renal Cell Carcinoma (Grawitz Tumor)
01/2015 - 10/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2004 - 03/2001
2Squamous Cell Carcinoma of Head and Neck
11/2020 - 09/2001
2Neuralgia (Stump Neuralgia)
01/2018 - 01/2012
2Peripheral Nervous System Diseases (PNS Diseases)
01/2018 - 01/2012
2Carcinogenesis
03/2017 - 05/2000
2Neoplasm Metastasis (Metastasis)
01/2014 - 09/2012
2Nausea
01/2012 - 11/2011
2Kidney Neoplasms (Kidney Cancer)
01/2009 - 10/2008
2Colonic Neoplasms (Colon Cancer)
12/2008 - 03/2001
2Diarrhea
01/2007 - 11/2002
2Mucositis
04/2005 - 04/2003
2Ovarian Neoplasms (Ovarian Cancer)
11/2004 - 05/2001
2Glioblastoma (Glioblastoma Multiforme)
04/2003 - 07/2002
2Head and Neck Neoplasms (Head and Neck Cancer)
07/2002 - 09/2001
2Colorectal Neoplasms (Colorectal Cancer)
10/2000 - 08/2000
1Painful Neuropathy
01/2018
1Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2017
1X-Linked Mental Retardation (Mental Retardation, X Linked)
03/2014
1Thalassemia
03/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
03/2014
1Hypoxia (Hypoxemia)
01/2014
1Fatigue
09/2012
1Lymphoma (Lymphomas)
09/2012
1Pain (Aches)
01/2012
1Vomiting
11/2011
1Alopecia (Baldness)
11/2011
1Meningioma (Meningiomas)
04/2011
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2011
1Thrombocytopenia (Thrombopenia)
01/2009
1Hemangiosarcoma (Angiosarcoma)
01/2009
1Stomatitis
01/2009
1Vaginal Neoplasms (Cancer, Vaginal)
01/2009
1Endometrial Neoplasms (Endometrial Cancer)
10/2008
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2008
1Thyroid Neoplasms (Thyroid Cancer)
01/2007

Drug/Important Bio-Agent (IBA)

5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2018 - 08/2000
5EverolimusFDA Link
01/2015 - 11/2004
5Pharmaceutical PreparationsIBA
12/2014 - 11/2002
5GemcitabineFDA Link
02/2014 - 01/2000
4Sirolimus (Rapamycin)FDA Link
01/2009 - 11/2004
4Antineoplastic Agents (Antineoplastics)IBA
12/2008 - 01/2000
3LigandsIBA
11/2020 - 01/2000
3Sunitinib (Sutent)FDA Link
02/2017 - 12/2014
3temsirolimusFDA Link
01/2009 - 04/2005
3ErbB Receptors (EGF Receptor)IBA
06/2003 - 01/2000
3Telomerase (Telomerase Reverse Transcriptase)IBA
03/2001 - 05/2000
2Biological ProductsIBA
03/2017 - 05/2000
2Proteins (Proteins, Gene)FDA Link
03/2014 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2009 - 10/2008
2Paclitaxel (Taxol)FDA LinkGeneric
01/2009 - 05/2001
2Cisplatin (Platino)FDA LinkGeneric
02/2004 - 05/2001
2N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA
10/2002 - 08/2002
2SulfonamidesIBA
10/2002 - 08/2002
1AntibodiesIBA
11/2020
1B7-H1 AntigenIBA
11/2020
1Sorafenib (BAY 43-9006)FDA Link
05/2015
1Transcription Factors (Transcription Factor)IBA
03/2014
1Aurora KinasesIBA
02/2014
1MSC1992371AIBA
02/2014
1Histones (Histone)IBA
01/2014
1tasquinimodIBA
01/2014
1Advanced Glycation End ProductsIBA
01/2014
1Toll-Like Receptor 4IBA
01/2014
1(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA
09/2012
1Transaminases (Aminotransferases)IBA
09/2012
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2012
1Alanine Transaminase (SGPT)IBA
09/2012
1Dihydrotachysterol (AT 10)IBA
09/2012
1Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
01/2012
1nintedanibIBA
11/2011
1Hormones (Hormone)IBA
11/2011
1Prednisone (Sone)FDA LinkGeneric
11/2011
1Docetaxel (Taxotere)FDA Link
11/2011
1Bevacizumab (Avastin)FDA Link
04/2011
110-propargyl-10-deazaaminopterinFDA Link
01/2011
1taxaneIBA
01/2009
1EnzymesIBA
01/2009
1ridaforolimusIBA
01/2009
13-ingenyl angelateIBA
12/2008
1Protein Isoforms (Isoforms)IBA
12/2008
1Cytotoxins (Cytolysins)IBA
12/2008
1ingenolIBA
12/2008
1Cyclin D1IBA
10/2008
1Mechanistic Target of Rapamycin Complex 1IBA
10/2008
1sapacitabineIBA
09/2007
1NucleosidesIBA
09/2007
1Cytarabine (Cytosar-U)FDA LinkGeneric
09/2007

Therapy/Procedure

11Therapeutics
05/2015 - 01/2000
10Drug Therapy (Chemotherapy)
05/2009 - 01/2000
4Radiotherapy
06/2003 - 12/2000
2Aftercare (After-Treatment)
01/2018 - 03/2014
1Prostatectomy (Retropubic Prostatectomy)
12/2017
1Operative Surgical Procedures
12/2017